The ideal environment for innovative companies that want to quickly and easily bring new innovations in personalized health to market.
Although small, Switzerland’s strong life sciences ecosystem offers a dense and experienced network of KOLs, companies, universities and suppliers. Switzerland is home to a globally unique life science cluster featuring multinational companies, startups and SMEs that together build a dense network of medtech, biotech and nanotech companies. The industry benefits from this cluster along the entire value chain to develop, produce and market new products and services all in one place.
The closeness of the relationship between science and industry in Switzerland is unique – creating a high innovation output. World’s leading universities, first class research facilities and modern patent protection allow Switzerland to remain a strong competitor in R&D of innovative healthcare solutions.
Start shaping the future of health and benefit from Switzerland's:
- central location offering direct access to the European market
- unique partnering and licensing opportunities
- pragmatic and pioneering regulations in the field of emerging technologies
- top talent in life sciences and technology
Switzerland looks back on a long tradition in life sciences and looks ahead to the convergence of data science and healthcare, ringing in a new era in life sciences. We make medicines personalized and we make health digital.
THE FUTURE OF PRECISION MEDICINE AND DIAGNOSTICS
Important technological innovations start their journey in Switzerland before being sent around the world. With its unique ecosystem of innovative startups, multinational pharmaceutical giants such as Roche, Novartis, Bayer or Abbott and world leading research institutes and hospitals, the Basel Area is continuously growing its network of digital health innovators. In one of the most recent COVID-19 examples, Roche Diagnostics International AG, based in Zug, launched a total of 15 new diagnostics solutions in 2020.
One of several initiatives and accelerators programs in Switzerland is DayOne, which aims to foster collaboration across disciplines and industries in precision medicine and digital health. The Swissbiolabs association in Olten (Solothurn) is specifically aimed at the diagnostics sector. Among other things, it organizes a startup challenge and operates an accelerator.
Switzerland as a business location forms the ideal breeding ground for innovations in medical technology.
THE FUTURE OF DATA ANALYTICS
Switzerland’s Health Valley is a dense network of more than 1,000 companies and 35,000 talents collaborating with 500 research labs to further innovations in life sciences. One of these innovative startups is Sophia Genetics, based in the Canton of Vaud , founded as a spin-off of EPFL in 2011. Through its AI platform it established the world’s largest data-driven medicine community network and now serves more than 1,000 hospitals worldwide.
Basel is the host city of Intelligent Health AI and the BioDataWorld Congress, two of the world leading conferences for health data science.
FUTURE OF HEALTH AND DISEASE MANAGEMENT
As sports, fitness and medical applications are converging, Swiss wearable tech is capitalising on the proximity to numerous international sports federations, digital health companies and countless medtech global leaders. The density and thematic scope of health and disease management companies as well as academic network substantially contribute to the centre of competence in health and disease management. The competence base for sensors, microtechnics, miniaturization, efficiency of electronics supply are just some of the strengths that distinguish Switzerland as a business location.
BOOST YOUR INNOVATION CAPACITY
“Switzerland is like one lab in a way” states Professor Geoff Richards, Director of the AO Research Institute Davos. The unique situation of close collaboration between industry and academia is extremely profitable for research translation and bringing forward valuable innovations. Research institute are crucial in shaping the digital future of medicine thus, numerous Swiss research institutes focus on educating the next generation of innovators, connecting know-how and expertise for a cohesive pipeline of innovations and translating these findings through industry collaborations, startups and early-stage investments.
This seamless network allows Switzerland to position itself as one of the most innovative countries and remain competitive in an evolving industry.